283 results on '"Kotagal, Vikas"'
Search Results
2. Regional serotonin terminal density in aging human brain: A [11C]DASB PET study
3. Visuospatial Performance on Spatial Navigation Task and DASB PET Correlates in Isolated REM Sleep Behavior Disorder (P8-9.011)
4. 505 Use of Expanded Access at Michigan Medicine and Associations with Neighborhood Factors
5. Cognitive correlates of dual tasking costs on the timed up and go test in Parkinson disease
6. Caregiver burden worsens in the second year after subthalamic nucleus deep brain stimulation for Parkinson's disease
7. Lecanemab
8. Serious adverse events following Normal Pressure Hydrocephalus surgery
9. Amyloid plaque burden and dual tasking impairments on the Timed up and go test in Parkinson disease (P5-11.006)
10. Lecanemab: Looking Before We Leap.
11. Apathy rating scores and β-amyloidopathy in patients with Parkinson disease at risk for cognitive decline
12. Neighborhood Social Determinants of Health in Patients Seen in Neurology Movement Disorders Clinics
13. Ethical aspects of prodromal synucleinopathy prognostic counseling
14. Neuroimaging and clinical predictors of fatigue in Parkinson disease
15. Non-exercise physical activity attenuates motor symptoms in Parkinson disease independent from nigrostriatal degeneration
16. Diabetes mellitus is independently associated with more severe cognitive impairment in Parkinson disease
17. Serotonin Transporter Imaging in Multiple System Atrophy and Parkinson's Disease
18. Isolated REM sleep behavior disorder in North American older adults in an integrated health care system
19. Risky driving and pedunculopontine nucleus-thalamic cholinergic denervation in Parkinson disease
20. Parkinson Syndromes
21. Prevalence of impaired odor identification in Parkinson disease with imaging evidence of nigrostriatal denervation
22. Racial differences in trust and risk disclosure preferences among older research volunteers screened for prodromal synucleinopathies (P17-13.002)
23. Where do patients get diagnosed with idiopathic Rapid Eye Movement Behavior Disorder? (P2-7.003)
24. Diabetes is associated with postural instability and gait difficulty in Parkinson disease
25. Racial Differences in Trust and Risk Disclosure Preferences Among Older Registered Research Volunteers Screened for Prodromal Synucleinopathies
26. Regional Serotonin Terminal Density in Aging Human Brain: A [11C]DASB Pet Study
27. Striatal and Cortical β-Amyloidopathy and Cognition in Parkinsonʼs Disease
28. Gender differences in cholinergic and dopaminergic deficits in Parkinson disease
29. Educational attainment and motor burden in Parkinsonʼs disease
30. Clinical Markers for Identifying Cholinergic Deficits in Parkinsonʼs Disease
31. Frequency of Cholinergic and Caudate Nucleus Dopaminergic Deficits Across the Predemented Cognitive Spectrum of Parkinson Disease and Evidence of Interaction Effects
32. Cost-Effectiveness of Transfers to Centers With Neurological Intensive Care Units After Intracerebral Hemorrhage
33. Advanced Age, Cardiovascular Risk Burden, and Timed Up and Go Test Performance in Parkinson Disease
34. A 26-Year-Old Woman with Recurrent Loss of Consciousness
35. Extra-nigral pathological conditions are common in Parkinsonʼs disease with freezing of gait: An in vivo positron emission tomography study
36. Thalamic cholinergic innervation and postural sensory integration function in Parkinson’s disease
37. Psychedelic‐assisted therapy for functional neurological disorders: A theoretical framework and review of prior reports
38. β-Amyloid and Postural Instability and Gait Difficulty in Parkinsonʼs Disease at Risk for Dementia
39. Cerebral Amyloid Deposition and Serotoninergic Innervation in Parkinson Disease
40. Acetazolamide-Responsive Ataxia
41. Heterogeneity of Cholinergic Denervation in Parkinsonʼs Disease without Dementia
42. An update on brain imaging in parkinsonian dementia
43. Symptoms of Rapid Eye Movement Sleep Behavior Disorder are Associated with Cholinergic Denervation in Parkinson Disease
44. Age and Life-Sustaining Treatment Preferences in Parkinson Disease
45. Thirty-Day Hospital Readmission and Surgical Complication Rates for Shunting in Normal Pressure Hydrocephalus
46. Natural History of Caregiver Burden After Deep Brain Stimulation for Parkinson Disease (4380)
47. Reply: Cognition and olfaction in Parkinson’s disease
48. Apathy rating scores and β-amyloidopathy in patients with Parkinson disease at risk for cognitive decline
49. Olfactory dysfunction, central cholinergic integrity and cognitive impairment in Parkinson’s disease
50. [18F]FDOPA PET and clinical features in parkinsonism due to manganism
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.